KLK3 and prostate carcinoma: Tectorigenin also reduced the expression of prostate-derived ETS factor (PDEF), prostate specific antigen(PSA), and insulin-like growth factor-1 (IGF-1) receptor mRNA in LNCaP prostate cancer cells [6].